Emerging Technologies for Epilepsy Surgery

Danika L Paulo1, Tyler J Ball1, Dario J Englot2

  • 1Department of Neurological Surgery, Vanderbilt University Medical Center, 1161 21st Avenue So. T4224 Medical Center North, Nashville, TN 37232-2380, USA.

Neurologic Clinics
|October 21, 2022
PubMed

Insights

For medically refractory epilepsy, early surgical evaluation is recommended. Surgical interventions, including resection and newer minimally invasive options, aim for seizure freedom and improved quality of life.

Area of Science:

  • Neurology
  • Neurosurgery

Background:

  • Medically refractory epilepsy affects quality of life and increases mortality.
  • Early surgical evaluation is crucial for patients unresponsive to two antiseizure medications.

Purpose of the Study:

  • To review current and emerging surgical and neuromodulation treatment options for medically refractory epilepsy.
  • To emphasize individualized treatment selection based on patient factors.

Main Methods:

  • Review of current literature on epilepsy surgery and neuromodulation.
  • Discussion of diagnostic workup, including imaging for epileptogenic zone localization.
  • Overview of surgical resection, minimally invasive ablation, and neuromodulation techniques.

Main Results:

  • Epilepsy surgery offers the highest chance of seizure freedom.
  • Minimally invasive and noninvasive options like neuromodulation and ablation are effective alternatives.
  • Technological advancements are driving new treatment development.

Conclusions:

  • Surgical evaluation should be considered early for refractory epilepsy.
  • Treatment selection must be personalized, balancing efficacy with patient preferences.
  • Ongoing research into new targets and techniques promises further advancements.